The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery

Inhibition of Eg5 Acts Synergistically with Checkpoint Abrogation in Promoting Mitotic Catastrophe

(2012) Y. Chen et al.   MOLECULAR CANCER RESEARCH

CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis

(2011) Ying Wai Chan et al.   CELL CYCLE

Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit

(2011) J. P. H. Chow et al.   MOLECULAR AND CELLULAR BIOLOGY

Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01

(2011) K. F. On et al.   MOLECULAR CANCER THERAPEUTICS

Cyclin A2-Cyclin-Dependent Kinase 2 Cooperates with the PLK1-SCF -TrCP1-EMI1-Anaphase-Promoting Complex/Cyclosome Axis To Promote Genome Reduplication in the Absence of Mitosis

(2009) H. T. Ma et al.   MOLECULAR AND CELLULAR BIOLOGY

Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor

(2009) Shinji Mizuarai et al.   Molecular Cancer

The Kinetics of p53 ActivationVersusCyclin E Accumulation Underlies the Relationship between the Spindle-assembly Checkpoint and the Postmitotic Checkpoint

(2008) Ying Wai Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit

(2008) Hiroyuki Nakajima et al.   JOURNAL OF CELL BIOLOGY

Meiotic Inactivation of Xenopus Myt1 by CDK/XRINGO, but Not CDK/Cyclin, via Site-Specific Phosphorylation

(2008) E. Josué Ruiz et al.   MOLECULAR CELL

Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe

(2008) Y W Chan et al.   ONCOGENE